Cargando…
放疗联合阿帕替尼治疗非小细胞肺癌的机制及研究前景
Non-small cell lung cancer is one of the most commom malignant tumor being harmful to people's life and health. Most of the patients have developed to the last stage which not suitable for surgical indications, so radiation and chemotherapy is the main treatment strategy. In recent years, with...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973393/ https://www.ncbi.nlm.nih.gov/pubmed/29277185 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.12.09 |
Ejemplares similares
-
EGFR-TKI联合放疗治疗晚期非小细胞肺癌的研究进展
Publicado: (2014) -
放疗联合免疫治疗非小细胞肺癌:前沿学术问题专家交流共识
Publicado: (2020) -
奥希替尼在非小细胞肺癌靶向治疗中的获得性耐药机制
Publicado: (2020) -
阿帕替尼对肺癌细胞侵袭迁移的影响及其作用机制
Publicado: (2019) -
环状RNA在非小细胞肺癌放疗抵抗中的研究进展
Publicado: (2021)